Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 2,971 | 2,339 | 2,930 | 2,268 | 1,918 |
| Gross Profit | 2,971 | 2,339 | 2,930 | 2,268 | 1,918 |
| Operating Expenses | 6,966 | 5,472 | 3,386 | 3,393 | 3,381 |
| Operating Income | -3,995 | -3,133 | -456 | -1,125 | -1,463 |
| Interest Expense | 399 | 420 | 398 | 350 | 366 |
| Other Income | -13 | 188 | -288 | -53 | -92 |
| Pre-tax Income | -4,407 | -3,365 | -1,142 | -1,528 | -1,921 |
| Net Income Continuous | -4,407 | -3,365 | -1,142 | -1,528 | -1,921 |
| Net Income | $-4,407 | $-3,365 | $-1,142 | $-1,528 | $-1,921 |
| EPS Basic Total Ops | -2.28 | -288.12 | -97.96 | -130.85 | -164.47 |
| EPS Basic Continuous Ops | -2.28 | -288.15 | -97.61 | -131.02 | -164.50 |
| EPS Diluted Total Ops | -2.28 | -288.12 | -97.96 | -130.85 | -164.47 |
| EPS Diluted Continuous Ops | -2.28 | -288.15 | -97.61 | -131.02 | -164.50 |
| EBITDA(a) | $-3,918 | $-3,056 | $-396 | $-1,046 | $-1,386 |